Healio
The doctor screens for thyroid cancer history, pancreatitis and gallbladder disease before starting incretin drugs, and checks in within four weeks of each dose step.
Recap by typeshit. Full story at Healio.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
A surgeon on social media says the FDA has received two death reports involving black-market retatrutide. No official FDA statement is linked.
Former NIGMS director Jeremy Berg walks through four decades of research behind GLP-1 drugs, from a hormone that breaks down in two minutes to weekly shots.
Researchers are engineering peptides that hold up in the gut and aim at specific cells, which could let precision medicines be taken by mouth instead of injected.
Loading…